Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies

34Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The dominant tibial muscular dystrophy (TMD) and recessive limb-girdle muscular dystrophy 2J are allelic disorders caused by mutations in the C-terminus of titin, a giant sarcomeric protein. Both clinical presentations were initially identified in a large Finnish family and linked to a founder mutation (FINmaj). To further understand the physiopathology of these two diseases, we generated a mouse model carrying the FINmaj mutation. In heterozygous mice, dystrophic myopathology appears late at 9 months of age in few distal muscles. In homozygous (HO) mice, the first signs appear in the Soleus at 1 month of age and extend to most muscles at 6 months of age. Interestingly, the heart is also severely affected in HO mice. The mutation leads to the loss of the very C-terminal end of titin and to a secondary deficiency of calpain 3, a partner of titin. By crossing the FINmaj model with a calpain 3-deficient model, the TMD phenotype was corrected, demonstrating a participation of calpain 3 in the pathogenesis of this disease. © The Author 2010. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Charton, K., Danièle, N., Vihola, A., Roudaut, C., Gicquel, E., Monjaret, F., … Richard, I. (2010). Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies. Human Molecular Genetics, 19(23), 4608–4624. https://doi.org/10.1093/hmg/ddq388

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free